A Clinical Study to Evaluate the Efficacy and Safety of D-2570 in the Treatment of Moderate to Severe Plaque Psoriasis

Abroad (travel likely)RecruitingPHASE3

Conditions

Plaque Psoriasis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Shanghai Skin Disease Hospital, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Yuling Shi) · shiyuling1973@126.com · +86 021-36803000

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Evaluate the Efficacy and Safety of D-2570 in Subjects With Moderate to Severe Plaque Psoriasis

Plaque Psoriasis

Abroad (travel likely)RecruitingPHASE3

Beijing, China

A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis

Psoriasis

Abroad (travel likely)RecruitingPHASE2

Birmingham, United States · Phoenix, United States

A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in Children and Adolescents From 6 Years to Less Than 18 Years of Age With Moderate to Severe Plaque Psoriasis

Moderate to Severe Plaque Psoriasis

Abroad (travel likely)RecruitingPHASE3

Fountain Valley, United States · Los Angeles, United States

A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis

Plaque Psoriasis

Abroad (travel likely)RecruitingPHASE3

Birmingham, United States · Birmingham, United States